2000
DOI: 10.1021/jo000943e
|View full text |Cite
|
Sign up to set email alerts
|

Multivalency Effects in Protein−Carbohydrate Interaction:  The Binding of the Shiga-like Toxin 1 Binding Subunit to Multivalent C-Linked Glycopeptides

Abstract: A series of monovalent and bivalent glycopeptides displaying a C-linked analogue of the Pk trisaccharide, the in vivo ligand for the pentavalent Shiga-like toxin binding subunit (SLT-1B), were prepared and evaluated as ligands for SLT-1B by isothermal titration microcalorimetry and competitive enzyme-linked immunosorbent assay (ELISA). Although none of the monovalent ligands showed any enhancement in affinity compared to O-methyl glycoside, two bivalent ligands show significant enhancements in affinity in assa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
50
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(52 citation statements)
references
References 27 publications
2
50
0
Order By: Relevance
“…[17] Toone et al developed bivalent C-linked P k -trisaccharide-based glycopeptides as affinity ligands for B-Slt in microcalorimetry studies. [18] Inhibition of BSlt binding to cells has been demonstrated to protect mice from infection by E. coli O157:H7. [19] Thus, it could be of great benefit to develop both a B-Slt antagonist to protect against E. coli infection, and a sensitive, accurate and rapid assay to detect the toxin.…”
Section: Introductionmentioning
confidence: 99%
“…[17] Toone et al developed bivalent C-linked P k -trisaccharide-based glycopeptides as affinity ligands for B-Slt in microcalorimetry studies. [18] Inhibition of BSlt binding to cells has been demonstrated to protect mice from infection by E. coli O157:H7. [19] Thus, it could be of great benefit to develop both a B-Slt antagonist to protect against E. coli infection, and a sensitive, accurate and rapid assay to detect the toxin.…”
Section: Introductionmentioning
confidence: 99%
“…Many groups have reported the multivalent effect and the generation of the multivalent compounds such as glycopeptides [14], glycocalixarenes [15], glycodendrimers [16], and glycopolymers [17]. In particular, glycopolymers carrying a saccharide at the side chain exhibit a large multivalent effect and applicability as biomaterials.…”
Section: Introductionmentioning
confidence: 99%
“…These provided evidence for different binding mechanisms, including bridging between toxin pentamers, depending on the nature of the spacer. [27] An interesting mix of chelation of binding sites within a single toxin and bridging between toxin molecules has been observed for the Shiga-like toxin with a multivalent molecule containing ten ligands. [9a] In a competitive ELISA assay, this dodecavalent system was seven orders of magnitude more effective than monovalent reference compounds.…”
mentioning
confidence: 99%